OptimizeRx Corp Net Cash Provided by (Used in) Financing Activities in USD from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
OptimizeRx Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • OptimizeRx Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$587K, a 8.28% increase year-over-year.
  • OptimizeRx Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$4.91M, a 117% decline from 2023.
  • OptimizeRx Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $28.2M.
  • OptimizeRx Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$19M, a 126% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

OptimizeRx Corp Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$587K +$53K +8.28% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q1 2024 -$640K -$509K -389% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q1 2023 -$131K -$389K -151% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $258K -$69.9M -99.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $70.2M +$70.1M +62476% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $112K -$232K -67.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $344K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2016 -$357K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q1 2014 $2.8M +$2.8M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q1 2013 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15

OptimizeRx Corp Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$4.91M -$33.1M -117% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 $28.2M +$47.2M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 -$19M -$92.9M -126% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2021 $73.9M +$75.8M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 -$1.9M -$24.1M -109% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-03-10
2019 $22.2M +$13.5M +155% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-08
2018 $8.69M +$9.08M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 -$390K -$32.6K -9.12% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 -$357K -$4.7M -108% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-08
2015 $4.35M +$1.55M +55.5% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-08
2014 $2.8M +$2.8M Jan 1, 2014 Dec 31, 2014 10-K 2016-03-15
2013 $0 $0 Jan 1, 2013 Dec 31, 2013 10-K 2015-09-16
2012 $0 -$443K -100% Jan 1, 2012 Dec 31, 2012 10-K 2013-03-12
2011 $443K -$1.72M -79.5% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-12
2010 $2.16M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.